Plate,Well Number,Well,Characteristics [Organism],Term Source 1 REF,Term Source 1 Accession,Characteristics [Cell Line],Term Source 2 REF,Term Source 2 Accession,Experimental Condition [Cell Line],"Cell Type\Genetic Subtype (Neve et al., Cancer Cell 2006)",Experimental Condition [Media],Experimental Condition [Compound],Experimental Condition [Dose],Experimental Condition [Time],Control Type,Control Comments,Channels,Comments,Cell Line Morphotype
22_lines_HI_comp_200145430,194,I2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,195,I3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,196,I4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,197,I5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,198,I6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,199,I7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,200,I8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,201,I9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,202,I10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,203,I11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,204,I12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,205,I13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,206,I14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,207,I15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,208,I16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,209,I17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,210,I18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,211,I19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,212,I20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,213,I21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,214,I22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,215,I23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,218,J2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,219,J3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,220,J4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,221,J5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,222,J6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,223,J7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,224,J8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,225,J9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,226,J10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,227,J11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,228,J12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,229,J13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,230,J14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,231,J15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,232,J16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,233,J17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,234,J18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,235,J19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,236,J20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,237,J21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,238,J22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,239,J23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,242,K2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,243,K3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,244,K4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,245,K5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,246,K6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,247,K7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,248,K8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,249,K9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,250,K10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,251,K11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,252,K12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,253,K13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,254,K14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,255,K15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,256,K16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,257,K17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,258,K18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,259,K19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,260,K20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,261,K21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,262,K22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,263,K23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,266,L2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,267,L3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,268,L4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,269,L5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,270,L6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,271,L7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,272,L8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,273,L9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,274,L10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,275,L11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,276,L12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,277,L13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,278,L14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,279,L15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,280,L16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,281,L17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,282,L18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,283,L19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,284,L20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,285,L21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,286,L22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,287,L23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,290,M2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,291,M3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,292,M4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,293,M5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,294,M6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,295,M7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,296,M8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,297,M9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,298,M10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,299,M11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,300,M12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,301,M13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,302,M14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,303,M15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,304,M16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,305,M17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,306,M18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,307,M19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,308,M20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,309,M21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,310,M22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,311,M23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,314,N2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,315,N3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,316,N4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,317,N5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,318,N6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,319,N7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,320,N8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,321,N9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,322,N10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,323,N11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,324,N12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,325,N13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,326,N14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,327,N15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,328,N16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,329,N17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,330,N18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,331,N19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,332,N20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,333,N21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,334,N22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,335,N23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,338,O2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,339,O3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,340,O4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,341,O5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,342,O6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,343,O7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,344,O8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,345,O9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,346,O10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,347,O11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,348,O12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,349,O13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,350,O14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,351,O15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,352,O16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,353,O17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,354,O18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,355,O19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,356,O20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,357,O21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,358,O22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,359,O23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 hydrocortisone + 10 ug/ml insulin + 20 ng/ml EGF + 100 ng/ml cholera toxin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,26,B2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,27,B3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,28,B4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,29,B5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,30,B6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,31,B7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,32,B8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,33,B9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,34,B10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,35,B11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,36,B12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,37,B13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,38,B14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,39,B15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,40,B16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,41,B17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,42,B18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,43,B19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,44,B20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,45,B21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,46,B22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,47,B23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,50,C2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,51,C3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,52,C4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,53,C5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,54,C6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,55,C7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,56,C8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,57,C9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,58,C10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,59,C11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,60,C12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,61,C13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,62,C14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,63,C15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,64,C16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,65,C17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,66,C18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,67,C19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,68,C20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,69,C21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,70,C22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,71,C23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,74,D2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,75,D3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,76,D4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,77,D5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,78,D6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,79,D7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,80,D8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,81,D9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,82,D10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,83,D11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,84,D12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,85,D13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,86,D14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,87,D15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,88,D16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,89,D17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,90,D18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,91,D19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,92,D20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,93,D21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,94,D22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,95,D23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,98,E2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,99,E3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,100,E4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,101,E5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,102,E6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,103,E7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,104,E8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,105,E9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,106,E10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,107,E11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,108,E12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,109,E13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,110,E14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,111,E15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,112,E16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,113,E17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,114,E18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,115,E19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,116,E20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,117,E21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,118,E22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,119,E23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,122,F2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,123,F3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,124,F4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,125,F5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,126,F6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,127,F7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,128,F8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,129,F9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,130,F10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,131,F11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,132,F12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,133,F13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,134,F14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,135,F15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,136,F16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,137,F17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,138,F18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,139,F19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,140,F20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,141,F21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,142,F22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,143,F23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,146,G2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,147,G3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,148,G4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,149,G5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,150,G6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,151,G7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,152,G8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,153,G9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,154,G10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,155,G11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,156,G12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,157,G13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,158,G14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,159,G15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,160,G16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,161,G17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,162,G18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,163,G19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,164,G20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,165,G21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,166,G22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,167,G23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,170,H2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,171,H3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,172,H4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,173,H5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,174,H6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,175,H7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,176,H8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,177,H9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,178,H10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,179,H11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,180,H12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,181,H13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,182,H14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,183,H15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,184,H16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,185,H17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,186,H18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,187,H19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,188,H20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,189,H21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,190,H22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,191,H23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,26,B2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,27,B3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,28,B4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,29,B5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,30,B6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,31,B7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,32,B8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,33,B9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,34,B10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,35,B11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,36,B12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,37,B13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,38,B14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,39,B15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,40,B16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,41,B17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,42,B18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,43,B19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,44,B20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,45,B21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,46,B22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,47,B23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,50,C2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,51,C3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,52,C4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,53,C5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,54,C6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,55,C7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,56,C8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,57,C9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,58,C10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,59,C11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,60,C12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,61,C13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,62,C14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,63,C15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,64,C16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,65,C17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,66,C18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,67,C19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,68,C20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,69,C21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,70,C22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,71,C23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,74,D2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,75,D3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,76,D4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,77,D5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,78,D6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,79,D7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,80,D8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,81,D9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,82,D10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,83,D11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,84,D12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,85,D13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,86,D14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,87,D15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,88,D16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,89,D17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,90,D18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,91,D19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,92,D20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,93,D21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,94,D22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,95,D23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,98,E2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,99,E3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,100,E4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,101,E5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,102,E6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,103,E7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,104,E8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,105,E9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,106,E10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,107,E11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,108,E12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,109,E13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,110,E14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,111,E15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,112,E16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,113,E17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,114,E18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,115,E19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,116,E20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,117,E21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,118,E22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,119,E23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,122,F2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,123,F3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,124,F4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,125,F5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,126,F6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,127,F7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,128,F8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,129,F9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,130,F10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,131,F11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,132,F12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,133,F13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,134,F14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,135,F15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,136,F16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,137,F17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,138,F18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,139,F19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,140,F20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,141,F21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,142,F22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,143,F23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,146,G2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,147,G3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,148,G4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,149,G5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,150,G6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,151,G7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,152,G8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,153,G9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,154,G10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,155,G11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,156,G12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,157,G13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,158,G14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,159,G15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,160,G16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,161,G17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,162,G18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,163,G19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,164,G20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,165,G21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,166,G22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,167,G23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,170,H2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,171,H3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,172,H4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,173,H5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,174,H6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,175,H7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,176,H8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,177,H9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,178,H10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,179,H11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,180,H12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,181,H13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,182,H14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,183,H15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,184,H16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,185,H17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,186,H18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HI_comp_200145430,187,H19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,188,H20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HI_comp_200145430,189,H21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HI_comp_200145430,190,H22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HI_comp_200145430,191,H23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 0.5 mg/ml hydrocortisone + 10 ug/ml insulin,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,194,I2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,195,I3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,196,I4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,197,I5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,198,I6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,199,I7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,200,I8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,201,I9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,202,I10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,203,I11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,204,I12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,205,I13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,206,I14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,207,I15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,208,I16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,209,I17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,210,I18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,211,I19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,212,I20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,213,I21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,214,I22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,215,I23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,218,J2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,219,J3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,220,J4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,221,J5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,222,J6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,223,J7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,224,J8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,225,J9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,226,J10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,227,J11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,228,J12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,229,J13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,230,J14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,231,J15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,232,J16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,233,J17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,234,J18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,235,J19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,236,J20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,237,J21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,238,J22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,239,J23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,242,K2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,243,K3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,244,K4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,245,K5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,246,K6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,247,K7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,248,K8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,249,K9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,250,K10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,251,K11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,252,K12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,253,K13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,254,K14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,255,K15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,256,K16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,257,K17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,258,K18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,259,K19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,260,K20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,261,K21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,262,K22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,263,K23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,266,L2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,267,L3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,268,L4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,269,L5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,270,L6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,271,L7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,272,L8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,273,L9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,274,L10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,275,L11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,276,L12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,277,L13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,278,L14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,279,L15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,280,L16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,281,L17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,282,L18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,283,L19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,284,L20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,285,L21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,286,L22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,287,L23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,290,M2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,291,M3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,292,M4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,293,M5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,294,M6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,295,M7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,296,M8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,297,M9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,298,M10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,299,M11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,300,M12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,301,M13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,302,M14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,303,M15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,304,M16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,305,M17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,306,M18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,307,M19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,308,M20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,309,M21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,310,M22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,311,M23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,314,N2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,315,N3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,316,N4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,317,N5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,318,N6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,319,N7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,320,N8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,321,N9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,322,N10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,323,N11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,324,N12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,325,N13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,326,N14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,327,N15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,328,N16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,329,N17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,330,N18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,331,N19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,332,N20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,333,N21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,334,N22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,335,N23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,338,O2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,339,O3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,340,O4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,341,O5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,342,O6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,343,O7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,344,O8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,345,O9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,346,O10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,347,O11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,348,O12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,349,O13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,350,O14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,351,O15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,352,O16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,353,O17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,354,O18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_HC_EGF_200145913,355,O19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,356,O20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,357,O21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_HC_EGF_200145913,358,O22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_HC_EGF_200145913,359,O23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS + 20 ng/ml EGF,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,26,B2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,27,B3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,28,B4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,29,B5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,30,B6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,31,B7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,32,B8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,33,B9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,34,B10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,35,B11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,36,B12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,37,B13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,38,B14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,39,B15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,40,B16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,41,B17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,42,B18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,43,B19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,44,B20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,45,B21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,46,B22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,47,B23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,50,C2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,51,C3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,52,C4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,53,C5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,54,C6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,55,C7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,56,C8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,57,C9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,58,C10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,59,C11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,60,C12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,61,C13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,62,C14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,63,C15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,64,C16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,65,C17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,66,C18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,67,C19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,68,C20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,69,C21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,70,C22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,71,C23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,74,D2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,75,D3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,76,D4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,77,D5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,78,D6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,79,D7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,80,D8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,81,D9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,82,D10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,83,D11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,84,D12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,85,D13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,86,D14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,87,D15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,88,D16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,89,D17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,90,D18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,91,D19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,92,D20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,93,D21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,94,D22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,95,D23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,98,E2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,99,E3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,100,E4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,101,E5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,102,E6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,103,E7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,104,E8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,105,E9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,106,E10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,107,E11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,108,E12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,109,E13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,110,E14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,111,E15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,112,E16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,113,E17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,114,E18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,115,E19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,116,E20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,117,E21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,118,E22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,119,E23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,122,F2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,123,F3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,124,F4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,125,F5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,126,F6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,127,F7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,128,F8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,129,F9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,130,F10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,131,F11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,132,F12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,133,F13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,134,F14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,135,F15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,136,F16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,137,F17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,138,F18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,139,F19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,140,F20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,141,F21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,142,F22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,143,F23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,146,G2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,147,G3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,148,G4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,149,G5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,150,G6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,151,G7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,152,G8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,153,G9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,154,G10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,155,G11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,156,G12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,157,G13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,158,G14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,159,G15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,160,G16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,161,G17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,162,G18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,163,G19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,164,G20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,165,G21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,166,G22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,167,G23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,170,H2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,171,H3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,172,H4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,173,H5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,174,H6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,175,H7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,176,H8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,177,H9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,178,H10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,179,H11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,180,H12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,181,H13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,182,H14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,183,H15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,184,H16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,185,H17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,186,H18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,187,H19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,188,H20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,189,H21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,190,H22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,191,H23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,194,I2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,195,I3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,196,I4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,197,I5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,198,I6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,199,I7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,200,I8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,201,I9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,202,I10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,203,I11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,204,I12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,205,I13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,206,I14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,207,I15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,208,I16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,209,I17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,210,I18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,211,I19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,212,I20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,213,I21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,214,I22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,215,I23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,218,J2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,219,J3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,220,J4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,221,J5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,222,J6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,223,J7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,224,J8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,225,J9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,226,J10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,227,J11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,228,J12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,229,J13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,230,J14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,231,J15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,232,J16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,233,J17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,234,J18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,235,J19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,236,J20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,237,J21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,238,J22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,239,J23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,242,K2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,243,K3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,244,K4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,245,K5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,246,K6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,247,K7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,248,K8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,249,K9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,250,K10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,251,K11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,252,K12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,253,K13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,254,K14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,255,K15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,256,K16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,257,K17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,258,K18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,259,K19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,260,K20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,261,K21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,262,K22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,263,K23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,266,L2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,267,L3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,268,L4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,269,L5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,270,L6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,271,L7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,272,L8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,273,L9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,274,L10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,275,L11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,276,L12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,277,L13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,278,L14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,279,L15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,280,L16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,281,L17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,282,L18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,283,L19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,284,L20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,285,L21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,286,L22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,287,L23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,290,M2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,291,M3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,292,M4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,293,M5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,294,M6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,295,M7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,296,M8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,297,M9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,298,M10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,299,M11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,300,M12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,301,M13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,302,M14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,303,M15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,304,M16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,305,M17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,306,M18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,307,M19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,308,M20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,309,M21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,310,M22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,311,M23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,314,N2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,315,N3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,316,N4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,317,N5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,318,N6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,319,N7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,320,N8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,321,N9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,322,N10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,323,N11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,324,N12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,325,N13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,326,N14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,327,N15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,328,N16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,329,N17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,330,N18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,331,N19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,332,N20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,333,N21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,334,N22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,335,N23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,338,O2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,339,O3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,340,O4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,341,O5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,342,O6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,343,O7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,344,O8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,345,O9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,346,O10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,347,O11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,348,O12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,349,O13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,350,O14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,351,O15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,352,O16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,353,O17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,354,O18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNF_1h_200145914,355,O19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,356,O20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNF_1h_200145914,357,O21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNF_1h_200145914,358,O22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNF_1h_200145914,359,O23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,1 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,26,B2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,27,B3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,28,B4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,29,B5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,30,B6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,31,B7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,32,B8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,33,B9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,34,B10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,35,B11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,36,B12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,37,B13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,38,B14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,39,B15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,40,B16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,41,B17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,42,B18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,43,B19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,44,B20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,45,B21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,46,B22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,47,B23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,50,C2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,51,C3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,52,C4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,53,C5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,54,C6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,55,C7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,56,C8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,57,C9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,58,C10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,59,C11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,60,C12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,61,C13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,62,C14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,63,C15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,64,C16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,65,C17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,66,C18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,67,C19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,68,C20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,69,C21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,70,C22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,71,C23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,74,D2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,75,D3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,76,D4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,77,D5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,78,D6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,79,D7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,80,D8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,81,D9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,82,D10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,83,D11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,84,D12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,85,D13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,86,D14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,87,D15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,88,D16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,89,D17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,90,D18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,91,D19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,92,D20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,93,D21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,94,D22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,95,D23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,98,E2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,99,E3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,100,E4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,101,E5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,102,E6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,103,E7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,104,E8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,105,E9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,106,E10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,107,E11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,108,E12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,109,E13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,110,E14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,111,E15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,112,E16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,113,E17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,114,E18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,115,E19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,116,E20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,117,E21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,118,E22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,119,E23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,122,F2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,123,F3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,124,F4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,125,F5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,126,F6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,127,F7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,128,F8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,129,F9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,130,F10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,131,F11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,132,F12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,133,F13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,134,F14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,135,F15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,136,F16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,137,F17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,138,F18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,139,F19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,140,F20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,141,F21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,142,F22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,143,F23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,146,G2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,147,G3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,148,G4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,149,G5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,150,G6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,151,G7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,152,G8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,153,G9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,154,G10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,155,G11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,156,G12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,157,G13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,158,G14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,159,G15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,160,G16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,161,G17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,162,G18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,163,G19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,164,G20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,165,G21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,166,G22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,167,G23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,170,H2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,171,H3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,172,H4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,173,H5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,174,H6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,175,H7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,176,H8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,177,H9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,178,H10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,179,H11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,180,H12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,181,H13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,182,H14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,183,H15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,184,H16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,185,H17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,186,H18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,187,H19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,188,H20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,189,H21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,190,H22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,191,H23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,194,I2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,195,I3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,196,I4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,197,I5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,198,I6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,199,I7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,200,I8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,201,I9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,202,I10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,203,I11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,204,I12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,205,I13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,206,I14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,207,I15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,208,I16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,209,I17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,210,I18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,211,I19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,212,I20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,213,I21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,214,I22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,215,I23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,218,J2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,219,J3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,220,J4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,221,J5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,222,J6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,223,J7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,224,J8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,225,J9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,226,J10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,227,J11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,228,J12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,229,J13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,230,J14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,231,J15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,232,J16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,233,J17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,234,J18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,235,J19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,236,J20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,237,J21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,238,J22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,239,J23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,242,K2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,243,K3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,244,K4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,245,K5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,246,K6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,247,K7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,248,K8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,249,K9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,250,K10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,251,K11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,252,K12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,253,K13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,254,K14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,255,K15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,256,K16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,257,K17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,258,K18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,259,K19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,260,K20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,261,K21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,262,K22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,263,K23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,266,L2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,267,L3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,268,L4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,269,L5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,270,L6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,271,L7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,272,L8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,273,L9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,274,L10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,275,L11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,276,L12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,277,L13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,278,L14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,279,L15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,280,L16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,281,L17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,282,L18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,283,L19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,284,L20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,285,L21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,286,L22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,287,L23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,290,M2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,291,M3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,292,M4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,293,M5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,294,M6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,295,M7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,296,M8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,297,M9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,298,M10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,299,M11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,300,M12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,301,M13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,302,M14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,303,M15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,304,M16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,305,M17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,306,M18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,307,M19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,308,M20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,309,M21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,310,M22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,311,M23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,314,N2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,315,N3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,316,N4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,317,N5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,318,N6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,319,N7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,320,N8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,321,N9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,322,N10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,323,N11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,324,N12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,325,N13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,326,N14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,327,N15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,328,N16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,329,N17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,330,N18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,331,N19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,332,N20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,333,N21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,334,N22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,335,N23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,338,O2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,339,O3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,340,O4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,341,O5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,342,O6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,343,O7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,344,O8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,345,O9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,346,O10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,347,O11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,348,O12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,349,O13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,350,O14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,351,O15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,352,O16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,353,O17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,354,O18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_TNFa_5h_200145427,355,O19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,356,O20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_TNFa_5h_200145427,357,O21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_TNFa_5h_200145427,358,O22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_TNFa_5h_200145427,359,O23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,TNF-alpha,10 nanogram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,26,B2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,27,B3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,28,B4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,29,B5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,30,B6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,31,B7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,32,B8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,33,B9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,34,B10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,35,B11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,36,B12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,37,B13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,38,B14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,39,B15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,40,B16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,41,B17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,42,B18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,43,B19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,44,B20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,45,B21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,46,B22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,47,B23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,50,C2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,51,C3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,52,C4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,53,C5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,54,C6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,55,C7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,56,C8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,57,C9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,58,C10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,59,C11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,60,C12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,61,C13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,62,C14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,63,C15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,64,C16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,65,C17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,66,C18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,67,C19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,68,C20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,69,C21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,70,C22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,71,C23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,74,D2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,75,D3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,76,D4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,77,D5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,78,D6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,79,D7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,80,D8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,81,D9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,82,D10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,83,D11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,84,D12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,85,D13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,86,D14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,87,D15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,88,D16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,89,D17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,90,D18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,91,D19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,92,D20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,93,D21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,94,D22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,95,D23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,98,E2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,99,E3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,100,E4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,101,E5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,102,E6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,103,E7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,104,E8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,105,E9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,106,E10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,107,E11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,108,E12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,109,E13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,110,E14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,111,E15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,112,E16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,113,E17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,114,E18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,115,E19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,116,E20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,117,E21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,118,E22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,119,E23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,122,F2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,123,F3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,124,F4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,125,F5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,126,F6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,127,F7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,128,F8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,129,F9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,130,F10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,131,F11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,132,F12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,133,F13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,134,F14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,135,F15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,136,F16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,137,F17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,138,F18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,139,F19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,140,F20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,141,F21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,142,F22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,143,F23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,146,G2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,147,G3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,148,G4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,149,G5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,150,G6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,151,G7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,152,G8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,153,G9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,154,G10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,155,G11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,156,G12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,157,G13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,158,G14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,159,G15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,160,G16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,161,G17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,162,G18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,163,G19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,164,G20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,165,G21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,166,G22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,167,G23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,170,H2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,171,H3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,172,H4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,173,H5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,174,H6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,175,H7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,176,H8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,177,H9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,178,H10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,179,H11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,180,H12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,181,H13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,182,H14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,183,H15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,184,H16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,185,H17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,186,H18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,187,H19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,188,H20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,189,H21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,190,H22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,191,H23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,194,I2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,195,I3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,196,I4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,197,I5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,198,I6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,199,I7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,200,I8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,201,I9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,202,I10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,203,I11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,204,I12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,205,I13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,206,I14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,207,I15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,208,I16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,209,I17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,210,I18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,211,I19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,212,I20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,213,I21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,214,I22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,215,I23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,218,J2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,219,J3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,220,J4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,221,J5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,222,J6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,223,J7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,224,J8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,225,J9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,226,J10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,227,J11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,228,J12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,229,J13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,230,J14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,231,J15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,232,J16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,233,J17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,234,J18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,235,J19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,236,J20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,237,J21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,238,J22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,239,J23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,242,K2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,243,K3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,244,K4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,245,K5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,246,K6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,247,K7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,248,K8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,249,K9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,250,K10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,251,K11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,252,K12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,253,K13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,254,K14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,255,K15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,256,K16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,257,K17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,258,K18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,259,K19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,260,K20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,261,K21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,262,K22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,263,K23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,266,L2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,267,L3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,268,L4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,269,L5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,270,L6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,271,L7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,272,L8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,273,L9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,274,L10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,275,L11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,276,L12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,277,L13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,278,L14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,279,L15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,280,L16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,281,L17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,282,L18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,283,L19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,284,L20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,285,L21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,286,L22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,287,L23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,290,M2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,291,M3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,292,M4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,293,M5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,294,M6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,295,M7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,296,M8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,297,M9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,298,M10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,299,M11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,300,M12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,301,M13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,302,M14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,303,M15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,304,M16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,305,M17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,306,M18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,307,M19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,308,M20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,309,M21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,310,M22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,311,M23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,314,N2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,315,N3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,316,N4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,317,N5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,318,N6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,319,N7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,320,N8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,321,N9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,322,N10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,323,N11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,324,N12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,325,N13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,326,N14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,327,N15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,328,N16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,329,N17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,330,N18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,331,N19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,332,N20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,333,N21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,334,N22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,335,N23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,338,O2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,339,O3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,340,O4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,341,O5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,342,O6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,343,O7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,344,O8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,345,O9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,346,O10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,347,O11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,348,O12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,349,O13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,350,O14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,351,O15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,352,O16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,353,O17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,354,O18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145425,355,O19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,356,O20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145425,357,O21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145425,358,O22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145425,359,O23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,26,B2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,27,B3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,28,B4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,29,B5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,30,B6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,31,B7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,32,B8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,33,B9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,34,B10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,35,B11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,36,B12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,37,B13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,38,B14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,39,B15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,40,B16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,41,B17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,42,B18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,43,B19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,44,B20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,45,B21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,46,B22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,47,B23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,50,C2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,51,C3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,52,C4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,53,C5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,54,C6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,55,C7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,56,C8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,57,C9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,58,C10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,59,C11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,60,C12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,61,C13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,62,C14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,63,C15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,64,C16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,65,C17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,66,C18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,67,C19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,68,C20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,69,C21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,70,C22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,71,C23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,74,D2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,75,D3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,76,D4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,77,D5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,78,D6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,79,D7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,80,D8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,81,D9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,82,D10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,83,D11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,84,D12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,85,D13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,86,D14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,87,D15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,88,D16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,89,D17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,90,D18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,91,D19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,92,D20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,93,D21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,94,D22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,95,D23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,98,E2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,99,E3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,100,E4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,101,E5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,102,E6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,103,E7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,104,E8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,105,E9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,106,E10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,107,E11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,108,E12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,109,E13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,110,E14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,111,E15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,112,E16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,113,E17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,114,E18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,115,E19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,116,E20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,117,E21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,118,E22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,119,E23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,122,F2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,123,F3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,124,F4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,125,F5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,126,F6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,127,F7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,128,F8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,129,F9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,130,F10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,131,F11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,132,F12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,133,F13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,134,F14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,135,F15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,136,F16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,137,F17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,138,F18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,139,F19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,140,F20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,141,F21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,142,F22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,143,F23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,146,G2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,147,G3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,148,G4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,149,G5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,150,G6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,151,G7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,152,G8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,153,G9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,154,G10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,155,G11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,156,G12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,157,G13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,158,G14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,159,G15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,160,G16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,161,G17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,162,G18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,163,G19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,164,G20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,165,G21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,166,G22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,167,G23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,170,H2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,171,H3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,172,H4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,173,H5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,174,H6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,175,H7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,176,H8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,177,H9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,178,H10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,179,H11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,180,H12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,181,H13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,182,H14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,183,H15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,184,H16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,185,H17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,186,H18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,187,H19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,188,H20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,189,H21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,190,H22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,191,H23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,194,I2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,195,I3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,196,I4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,197,I5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,198,I6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,199,I7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,200,I8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,201,I9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,202,I10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,203,I11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,204,I12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,205,I13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,206,I14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,207,I15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,208,I16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,209,I17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,210,I18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,211,I19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,212,I20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,213,I21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,214,I22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,215,I23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,218,J2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,219,J3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,220,J4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,221,J5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,222,J6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,223,J7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,224,J8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,225,J9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,226,J10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,227,J11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,228,J12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,229,J13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,230,J14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,231,J15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,232,J16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,233,J17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,234,J18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,235,J19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,236,J20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,237,J21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,238,J22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,239,J23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,242,K2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,243,K3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,244,K4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,245,K5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,246,K6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,247,K7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,248,K8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,249,K9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,250,K10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,251,K11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,252,K12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,253,K13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,254,K14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,255,K15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,256,K16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,257,K17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,258,K18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,259,K19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,260,K20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,261,K21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,262,K22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,263,K23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,266,L2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,267,L3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,268,L4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,269,L5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,270,L6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,271,L7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,272,L8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,273,L9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,274,L10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,275,L11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,276,L12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,277,L13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,278,L14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,279,L15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,280,L16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,281,L17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,282,L18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,283,L19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,284,L20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,285,L21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,286,L22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,287,L23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,290,M2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,291,M3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,292,M4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,293,M5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,294,M6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,295,M7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,296,M8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,297,M9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,298,M10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,299,M11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,300,M12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,301,M13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,302,M14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,303,M15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,304,M16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,305,M17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,306,M18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,307,M19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,308,M20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,309,M21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,310,M22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,311,M23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,314,N2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,315,N3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,316,N4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,317,N5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,318,N6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,319,N7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,320,N8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,321,N9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,322,N10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,323,N11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,324,N12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,325,N13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,326,N14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,327,N15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,328,N16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,329,N17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,330,N18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,331,N19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,332,N20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,333,N21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,334,N22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,335,N23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,338,O2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,339,O3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,340,O4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,341,O5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,342,O6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,343,O7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,344,O8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,345,O9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,346,O10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,347,O11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,348,O12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,349,O13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,350,O14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,351,O15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,352,O16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,353,O17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,354,O18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_untreated_200145426,355,O19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,356,O20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_untreated_200145426,357,O21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_untreated_200145426,358,O22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_untreated_200145426,359,O23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,none,,,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,26,B2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,27,B3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,28,B4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,29,B5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,30,B6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,31,B7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,32,B8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,33,B9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,34,B10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,35,B11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,36,B12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,37,B13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,38,B14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,39,B15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,40,B16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,41,B17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,42,B18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,43,B19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,44,B20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,45,B21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,46,B22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,47,B23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,50,C2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,51,C3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,52,C4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,53,C5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,54,C6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,55,C7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,56,C8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,57,C9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,58,C10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,59,C11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,60,C12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,61,C13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,62,C14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,63,C15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,64,C16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,65,C17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,66,C18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,67,C19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,68,C20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,69,C21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,70,C22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,71,C23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,74,D2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,75,D3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,76,D4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,77,D5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,78,D6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,79,D7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,80,D8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,81,D9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,82,D10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,83,D11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,84,D12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,85,D13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,86,D14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,87,D15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,88,D16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,89,D17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,90,D18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,91,D19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,92,D20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,93,D21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,94,D22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,95,D23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,98,E2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,99,E3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,100,E4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,101,E5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,102,E6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,103,E7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,104,E8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,105,E9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,106,E10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,107,E11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,108,E12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,109,E13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,110,E14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,111,E15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,112,E16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,113,E17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,114,E18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,115,E19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,116,E20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,117,E21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,118,E22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,119,E23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,122,F2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,123,F3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,124,F4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,125,F5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,126,F6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,127,F7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,128,F8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,129,F9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,130,F10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,131,F11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,132,F12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,133,F13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,134,F14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,135,F15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,136,F16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,137,F17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,138,F18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,139,F19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,140,F20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,141,F21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,142,F22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,143,F23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,146,G2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,147,G3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,148,G4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,149,G5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,150,G6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,151,G7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,152,G8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,153,G9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,154,G10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,155,G11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,156,G12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,157,G13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,158,G14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,159,G15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,160,G16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,161,G17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,162,G18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,163,G19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,164,G20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,165,G21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,166,G22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,167,G23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,170,H2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,171,H3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,172,H4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,173,H5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,174,H6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,175,H7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,176,H8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,177,H9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,178,H10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,179,H11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,180,H12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,181,H13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,182,H14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,183,H15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,184,H16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,185,H17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,186,H18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,187,H19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,188,H20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,189,H21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,190,H22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,191,H23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,Y-27632,10 micromolar,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,194,I2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,195,I3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,196,I4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,197,I5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,198,I6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,199,I7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,200,I8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,201,I9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,202,I10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,203,I11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,204,I12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,205,I13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,206,I14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,207,I15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,208,I16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,209,I17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,210,I18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,211,I19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,212,I20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,213,I21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,214,I22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,215,I23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,218,J2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,219,J3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,220,J4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,221,J5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,222,J6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,223,J7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,224,J8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,225,J9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,226,J10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,227,J11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,228,J12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,229,J13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,230,J14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,231,J15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,232,J16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,233,J17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,234,J18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,235,J19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,236,J20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,237,J21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,238,J22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,239,J23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,242,K2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,243,K3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,244,K4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,245,K5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,246,K6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,247,K7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,248,K8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,249,K9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,250,K10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,251,K11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,252,K12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,253,K13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,254,K14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,255,K15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,256,K16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,257,K17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,258,K18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,259,K19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,260,K20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,261,K21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,262,K22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,263,K23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,266,L2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,267,L3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,268,L4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,269,L5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,270,L6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,271,L7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,272,L8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,273,L9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,274,L10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,275,L11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,276,L12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,277,L13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,278,L14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,279,L15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,280,L16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,281,L17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,282,L18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,283,L19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,284,L20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,285,L21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,286,L22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,287,L23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,290,M2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,291,M3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,292,M4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,293,M5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,294,M6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,295,M7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,296,M8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,297,M9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,298,M10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,299,M11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,300,M12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,301,M13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,302,M14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,303,M15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,304,M16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,305,M17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,306,M18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,307,M19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,308,M20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,309,M21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,310,M22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,311,M23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,314,N2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,315,N3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,316,N4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,317,N5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,318,N6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,319,N7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,320,N8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,321,N9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,322,N10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,323,N11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,324,N12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,325,N13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,326,N14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,327,N15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,328,N16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,329,N17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,330,N18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,331,N19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,332,N20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,333,N21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,334,N22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,335,N23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,338,O2,Homo sapiens,NCBITaxon,NCBITaxon_9606,HeLa,EFO,EFO_0001185,HeLa,cervical carcinoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,339,O3,Homo sapiens,NCBITaxon,NCBITaxon_9606,Hep3B,EFO,EFO_0002205,Hep3B,hepatoma,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,340,O4,Homo sapiens,NCBITaxon,NCBITaxon_9606,AG1573,,,AG1573,primary fibroblast,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,341,O5,Homo sapiens,NCBITaxon,NCBITaxon_9606,HS578T,EFO,EFO_0001192,HS578T,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,342,O6,Homo sapiens,NCBITaxon,NCBITaxon_9606,T47D,EFO,EFO_0001247,T47D,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,343,O7,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-157,EFO,EFO_0001206,MDA-MB-157,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,344,O8,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1143,EFO,EFO_0001169,HCC1143,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,345,O9,Homo sapiens,NCBITaxon,NCBITaxon_9606,AU565,EFO,EFO_0001087,AU565,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,346,O10,Homo sapiens,NCBITaxon,NCBITaxon_9606,ZR75.1,EFO,EFO_0001262,ZR75.1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,347,O11,Homo sapiens,NCBITaxon,NCBITaxon_9606,CAMA1,EFO,EFO_0001100,CAMA1,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,348,O12,Homo sapiens,NCBITaxon,NCBITaxon_9606,BT474,EFO,EFO_0001093,BT474,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,349,O13,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-231,EFO,EFO_0001209,MDA-MB-231,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,350,O14,Homo sapiens,NCBITaxon,NCBITaxon_9606,SKBR3,EFO,EFO_0001236,SKBR3,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,351,O15,Homo sapiens,NCBITaxon,NCBITaxon_9606,JIMT1,EFO,EFO_0005388,JIMT1,Breast cancer (unknown genetic subtype),DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,352,O16,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF7,EFO,EFO_0001203,MCF7,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,353,O17,Homo sapiens,NCBITaxon,NCBITaxon_9606,MDA-MB-453,EFO,EFO_0001215,MDA-MB-453,Luminal breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,354,O18,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC1954,EFO,EFO_0001175,HCC1954,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 1 - cobblestone (L1 cluster)
22_lines_Y27_noc_200145912,355,O19,Homo sapiens,NCBITaxon,NCBITaxon_9606,HCC70,EFO,EFO_0001181,HCC70,Basal A breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,356,O20,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM149,EFO,EFO_0001240,SUM149,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_Y27_noc_200145912,357,O21,Homo sapiens,NCBITaxon,NCBITaxon_9606,SUM159,EFO,EFO_0001241,SUM159,Basal B breast cancer,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal/Mesenchymal (L/B cluster)
22_lines_Y27_noc_200145912,358,O22,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF10A,EFO,EFO_0001200,MCF10A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Luminal 2 - small clustered (L2 cluster)
22_lines_Y27_noc_200145912,359,O23,Homo sapiens,NCBITaxon,NCBITaxon_9606,MCF12A,EFO,EFO_0001202,MCF12A,Basal B non-tumor,DMEM:F12 + 5% HI-FBS,nocodazole,2 microgram per milliliter,5 hour,,,DAPI: nuclei;Alexa-488: NF-kappaB;dihydroethidium(DHE): cell bodies,,Mesenchymal (B cluster)
22_lines_HC_EGF_200145913,1,A1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,2,A2,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,3,A3,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,4,A4,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,5,A5,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,6,A6,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,7,A7,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,8,A8,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,9,A9,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,10,A10,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,11,A11,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,12,A12,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,13,A13,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,14,A14,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,15,A15,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,16,A16,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,17,A17,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,18,A18,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,19,A19,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,20,A20,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,21,A21,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,22,A22,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,23,A23,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,24,A24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,25,B1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,48,B24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,49,C1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,72,C24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,73,D1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,96,D24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,97,E1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,120,E24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,121,F1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,144,F24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,145,G1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,168,G24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,169,H1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,192,H24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,193,I1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,216,I24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,217,J1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,240,J24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,241,K1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,264,K24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,265,L1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,288,L24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,289,M1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,312,M24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,313,N1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,336,N24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,337,O1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,360,O24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,361,P1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,362,P2,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,363,P3,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,364,P4,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,365,P5,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,366,P6,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,367,P7,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,368,P8,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,369,P9,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,370,P10,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,371,P11,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,372,P12,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,373,P13,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,374,P14,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,375,P15,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,376,P16,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,377,P17,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,378,P18,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,379,P19,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,380,P20,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,381,P21,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,382,P22,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,383,P23,,,,,,,,,,,,,empty well,,,no images,
22_lines_HC_EGF_200145913,384,P24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,1,A1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,2,A2,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,3,A3,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,4,A4,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,5,A5,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,6,A6,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,7,A7,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,8,A8,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,9,A9,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,10,A10,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,11,A11,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,12,A12,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,13,A13,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,14,A14,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,15,A15,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,16,A16,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,17,A17,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,18,A18,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,19,A19,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,20,A20,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,21,A21,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,22,A22,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,23,A23,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,24,A24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,25,B1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,48,B24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,49,C1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,72,C24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,73,D1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,96,D24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,97,E1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,120,E24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,121,F1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,144,F24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,145,G1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,168,G24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,169,H1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,192,H24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,193,I1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,216,I24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,217,J1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,240,J24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,241,K1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,264,K24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,265,L1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,288,L24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,289,M1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,312,M24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,313,N1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,336,N24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,337,O1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,360,O24,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,361,P1,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,362,P2,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,363,P3,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,364,P4,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,365,P5,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,366,P6,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,367,P7,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,368,P8,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,369,P9,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,370,P10,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,371,P11,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,372,P12,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,373,P13,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,374,P14,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,375,P15,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,376,P16,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,377,P17,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,378,P18,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,379,P19,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,380,P20,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,381,P21,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,382,P22,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,383,P23,,,,,,,,,,,,,empty well,,,no images,
22_lines_HI_comp_200145430,384,P24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,1,A1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,2,A2,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,3,A3,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,4,A4,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,5,A5,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,6,A6,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,7,A7,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,8,A8,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,9,A9,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,10,A10,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,11,A11,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,12,A12,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,13,A13,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,14,A14,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,15,A15,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,16,A16,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,17,A17,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,18,A18,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,19,A19,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,20,A20,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,21,A21,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,22,A22,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,23,A23,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,24,A24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,25,B1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,48,B24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,49,C1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,72,C24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,73,D1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,96,D24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,97,E1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,120,E24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,121,F1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,144,F24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,145,G1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,168,G24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,169,H1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,192,H24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,193,I1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,216,I24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,217,J1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,240,J24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,241,K1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,264,K24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,265,L1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,288,L24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,289,M1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,312,M24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,313,N1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,336,N24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,337,O1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,360,O24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,361,P1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,362,P2,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,363,P3,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,364,P4,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,365,P5,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,366,P6,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,367,P7,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,368,P8,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,369,P9,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,370,P10,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,371,P11,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,372,P12,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,373,P13,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,374,P14,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,375,P15,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,376,P16,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,377,P17,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,378,P18,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,379,P19,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,380,P20,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,381,P21,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,382,P22,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,383,P23,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNF_1h_200145914,384,P24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,1,A1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,2,A2,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,3,A3,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,4,A4,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,5,A5,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,6,A6,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,7,A7,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,8,A8,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,9,A9,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,10,A10,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,11,A11,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,12,A12,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,13,A13,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,14,A14,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,15,A15,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,16,A16,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,17,A17,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,18,A18,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,19,A19,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,20,A20,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,21,A21,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,22,A22,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,23,A23,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,24,A24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,25,B1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,48,B24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,49,C1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,72,C24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,73,D1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,96,D24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,97,E1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,120,E24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,121,F1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,144,F24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,145,G1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,168,G24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,169,H1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,192,H24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,193,I1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,216,I24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,217,J1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,240,J24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,241,K1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,264,K24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,265,L1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,288,L24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,289,M1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,312,M24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,313,N1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,336,N24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,337,O1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,360,O24,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,361,P1,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,362,P2,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,363,P3,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,364,P4,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,365,P5,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,366,P6,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,367,P7,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,368,P8,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,369,P9,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,370,P10,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,371,P11,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,372,P12,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,373,P13,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,374,P14,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,375,P15,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,376,P16,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,377,P17,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,378,P18,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,379,P19,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,380,P20,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,381,P21,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,382,P22,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,383,P23,,,,,,,,,,,,,empty well,,,no images,
22_lines_TNFa_5h_200145427,384,P24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,1,A1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,2,A2,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,3,A3,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,4,A4,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,5,A5,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,6,A6,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,7,A7,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,8,A8,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,9,A9,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,10,A10,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,11,A11,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,12,A12,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,13,A13,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,14,A14,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,15,A15,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,16,A16,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,17,A17,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,18,A18,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,19,A19,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,20,A20,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,21,A21,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,22,A22,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,23,A23,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,24,A24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,25,B1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,48,B24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,49,C1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,72,C24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,73,D1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,96,D24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,97,E1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,120,E24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,121,F1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,144,F24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,145,G1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,168,G24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,169,H1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,192,H24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,193,I1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,216,I24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,217,J1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,240,J24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,241,K1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,264,K24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,265,L1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,288,L24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,289,M1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,312,M24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,313,N1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,336,N24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,337,O1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,360,O24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,361,P1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,362,P2,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,363,P3,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,364,P4,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,365,P5,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,366,P6,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,367,P7,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,368,P8,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,369,P9,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,370,P10,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,371,P11,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,372,P12,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,373,P13,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,374,P14,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,375,P15,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,376,P16,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,377,P17,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,378,P18,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,379,P19,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,380,P20,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,381,P21,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,382,P22,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,383,P23,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145425,384,P24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,1,A1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,2,A2,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,3,A3,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,4,A4,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,5,A5,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,6,A6,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,7,A7,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,8,A8,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,9,A9,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,10,A10,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,11,A11,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,12,A12,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,13,A13,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,14,A14,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,15,A15,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,16,A16,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,17,A17,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,18,A18,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,19,A19,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,20,A20,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,21,A21,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,22,A22,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,23,A23,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,24,A24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,25,B1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,48,B24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,49,C1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,72,C24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,73,D1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,96,D24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,97,E1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,120,E24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,121,F1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,144,F24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,145,G1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,168,G24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,169,H1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,192,H24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,193,I1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,216,I24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,217,J1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,240,J24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,241,K1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,264,K24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,265,L1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,288,L24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,289,M1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,312,M24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,313,N1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,336,N24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,337,O1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,360,O24,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,361,P1,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,362,P2,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,363,P3,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,364,P4,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,365,P5,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,366,P6,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,367,P7,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,368,P8,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,369,P9,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,370,P10,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,371,P11,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,372,P12,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,373,P13,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,374,P14,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,375,P15,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,376,P16,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,377,P17,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,378,P18,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,379,P19,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,380,P20,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,381,P21,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,382,P22,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,383,P23,,,,,,,,,,,,,empty well,,,no images,
22_lines_untreated_200145426,384,P24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,1,A1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,2,A2,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,3,A3,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,4,A4,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,5,A5,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,6,A6,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,7,A7,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,8,A8,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,9,A9,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,10,A10,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,11,A11,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,12,A12,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,13,A13,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,14,A14,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,15,A15,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,16,A16,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,17,A17,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,18,A18,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,19,A19,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,20,A20,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,21,A21,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,22,A22,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,23,A23,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,24,A24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,25,B1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,48,B24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,49,C1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,72,C24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,73,D1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,96,D24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,97,E1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,120,E24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,121,F1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,144,F24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,145,G1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,168,G24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,169,H1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,192,H24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,193,I1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,216,I24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,217,J1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,240,J24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,241,K1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,264,K24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,265,L1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,288,L24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,289,M1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,312,M24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,313,N1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,336,N24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,337,O1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,360,O24,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,361,P1,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,362,P2,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,363,P3,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,364,P4,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,365,P5,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,366,P6,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,367,P7,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,368,P8,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,369,P9,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,370,P10,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,371,P11,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,372,P12,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,373,P13,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,374,P14,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,375,P15,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,376,P16,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,377,P17,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,378,P18,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,379,P19,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,380,P20,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,381,P21,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,382,P22,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,383,P23,,,,,,,,,,,,,empty well,,,no images,
22_lines_Y27_noc_200145912,384,P24,,,,,,,,,,,,,empty well,,,no images,
